Case Study: Enhancing COVID-19 Diagnosis Identification

In response to challenges posed by today’s decentralized COVID-19 testing landscape, the University of Minnesota teamed up with Switchboard, MD to enhance their clinical trial data collection for developing COVID-19 treatments. Leveraging Switchboard, MD's MDAware model, the partnership focused on identifying COVID-positive patients from communication they sent to their providers, specifically through patient portal messages.

In October 2022, the University of Minnesota teamed up with Switchboard, MD to identify and integrate COVID-related patient messages into their clinical trial workflow. This enabled researchers to have more timely, accurate data for their clinical trials — resulting in:

Our collaboration with the University of Minnesota showcases the positive impacts of our innovative approach to clinical trial workflow. This case study highlights the importance of finding the right-sized AI for your organization and using advanced technologies to overcome healthcare challenges.

For more details, explore the full case study below: